Jacques Nasstrom

Jacques Nasstrom possesses extensive experience in the pharmaceutical and biotechnology sectors, serving in various leadership roles such as Owner of JoY Pharma AB and J&Y Pharma Consulting AB, Principal Scientist and Chief Scientific Officer at Egetis Therapeutics AB, and VP and Chief Scientific Advisor at PledPharma AB. A former Director of R&D at Q-Med, Investment Manager at Karolinska Investment Fund, and CEO of Accuro Immunology, Jacques has demonstrated expertise in developing innovative therapies, particularly for chemotherapy-induced peripheral neuropathy and cancer immunotherapy. Jacques holds a PhD in Pharmacology from Uppsala University, an MBA in General Management from Stockholm School of Economics, and a Master's degree in Pharmacy from Uppsala University.